Search for European Projects

8 European Projects Found

Searched on 125080 European Projects

 FINISHED 
Diabetes mellitus is a chronic disease characterised by high blood glucose due to inadequate insulin production and/or insulin resistance which affects 382 million people worldwide. Pancreatic islet transplantation is an extremely promising cure for insulin-sensitive diabetes mellitus (ISDM), but side effects of lifelong systemic immunosuppressive therapy, short supply of donor islets and their po ...
Read Project

 14

 FINISHED 

Living Architecture (LIAR)

Start date: Apr 1, 2016, End date: Mar 31, 2019,

Living Architecture (LIAR) is a modular bioreactor-wall, which is based on the operational principles of microbial fuel cell technology and synthetic ‘consortia’ of microbes. LIAR is conceived as a next-generation selectively-programmable bioreactor and integral component of human dwelling, capable of extracting valuable resources from waste water and air, generation of oxygen and production of p ...
Read Project

 7

 FINISHED 

Advanced Materials for Cardiac Regeneration (AMCARE) (AMCARE)

Start date: Nov 1, 2013, End date: Oct 31, 2017,

The Advanced Materials for Cardiac Regeneration (AMCARE) consortium aims to establish a translational research program to develop truly restorative therapies for acute myocardial infarction repair (MI) by optimising cardiac progenitor cell (CPC) therapy using smart biomaterials and advanced drug delivery, and coupling these therapeutics with minimally-invasive surgical devices. Two distinct biomat ...
Read Project

 10

 FINISHED 
"Diabetes is caused by insufficient or lack of insulin secretion by the specialized B cells of the pancreas and, if not treated adequately evolves into in complications which alter patients integrity and wellness. Treatment is based on lifetime drugs administration for blood glucose control or parenteral infusion of insulin to better control glucose levels and glycosylation of hemoglobin. Artifici ...
Read Project

 6

 FINISHED 
TOPCAPI will exploit the natural fabrication power of actinomycetes as microbial cell factories to produce three high value compounds: GE2270, a starter compound for the semi-synthesis of NAI-Acne, a new topical anti-acne drug in Phase II clinical trials; 6-desmethyl-tetracycline (6DM-TC) and 6-desmethyl 6-deshydro tetracycline (6DM6DH-TC), intermediates for semi-synthetic conversion to medically ...
Read Project

 8

 FINISHED 
"The concept of THE GRAIL project is the creation of an in vivo, in situ structured bioactive, selectively porous, bioresorbable scaffold that locally regenerates intima growth after endovascular treatment of the obstructed arteries in patients with atherosclerosis. Arterial obstruction due to arteriosclerosis is the cause of a wide spectrum of diseases, disabilities and death, because of induced ...
Read Project

 9

 FINISHED 

Magnetic Scaffolds for in vivo Tissue Engineering (MAGISTER)

Start date: Dec 1, 2008, End date: Nov 30, 2012,

The main driving idea of the project is the creation of conceptually new type of scaffolds able to be manipulated in situ by means of magnetic forces. This approach is expected to generate scaffolds with such characteristics as multiple use and possibly multipurpose delivery in order to repair large bone defects and ostheocondral lesions in the articular surface of the skeletal system. The major ...
Read Project

 21

 FINISHED 
"Bioethanol has been increasingly becoming the renewable energy source that could reduce the oil dependence of the developed countries. Biorefineries can use the locally grown agriculture to produce ethanol. However, food chain supply is beginning to suffer the effects of the ethanol massive production raising major ethical concerns. Cellulosic ethanol can overcome the environmental risks that acc ...
Read Project

 9